skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:033123/0449   Pages: 6
Recorded: 06/04/2014
Attorney Dkt #:P-212
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 4
1
Patent #:
Issue Dt:
07/20/2010
Application #:
11439671
Filing Dt:
05/24/2006
Publication #:
Pub Dt:
11/30/2006
Title:
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4, RECEPTOR AGONISTS
2
Patent #:
Issue Dt:
03/27/2012
Application #:
11920817
Filing Dt:
11/20/2007
Publication #:
Pub Dt:
08/20/2009
Title:
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
3
Patent #:
Issue Dt:
02/19/2013
Application #:
12796902
Filing Dt:
06/09/2010
Publication #:
Pub Dt:
09/30/2010
Title:
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
4
Patent #:
NONE
Issue Dt:
Application #:
13742783
Filing Dt:
01/16/2013
Publication #:
Pub Dt:
10/17/2013
Title:
AC/DC Multi-phase Converter Including Power Factor Correction Circuits with Regulated Output
Assignor
1
Exec Dt:
06/01/2014
Assignee
1
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA USA 94080
Correspondence name and address
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 06/16/2024 02:10 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT